Oral terbinafine provides systemic treatment, reaching the nail bed and deeper skin layers, which is essential for onychomycosis and extensive dermatophyte infections. Topical creams act locally and are generally limited to mild skin infections; they do not achieve therapeutic concentrations in nails.
Yes. Terbinafine’s absorption is not significantly affected by food, so it may be taken with or without meals according to patient preference.
Nail growth is slow; a fully healthy nail may require 6-12 months to grow out after the 12-week course, even though the fungus is eradicated at the end of treatment.
Terbinafine may interact with supplements that affect CYP2D6 activity, such as St. John’s wort (an inducer) or certain herbal preparations that inhibit CYP enzymes. Patients should disclose all supplements to their pharmacist.
Mild, transient elevations are common and often resolve without intervention. However, any rise in liver enzymes should be evaluated, and therapy may be paused or discontinued if levels become clinically significant.
Hair loss is not a recognized side effect of terbinafine. If a patient experiences unexpected alopecia, alternative causes should be investigated.
Terbinafine can affect taste buds, leading to dysgeusia or a metallic taste. This side effect is usually temporary and resolves after discontinuation of the medication.
No direct effect on glucose metabolism has been documented. Diabetic patients should continue routine monitoring as per their diabetes management plan.
Terbinafine can be taken with water during travel. It is advisable to keep the medication in its original packaging to avoid customs issues and to stay hydrated to minimize potential gastrointestinal discomfort.
Terbinafine is already widely available as a generic medication in Hong Kong; multiple manufacturers supply the 250 mg tablet, ensuring competitive pricing and accessibility.
Terbinafine is an antifungal agent available as a generic medication and marketed under brand names such as Lamisil, Exoderil, and Terbinafine-HCl. It belongs to the allylamine class of antifungals and is supplied in oral pill form, typically in a 250 mg strength. In Hong Kong, terbinafine is prescription-only and regulated by the Department of Health.
Terbinafine exerts its antifungal effect by inhibiting the enzyme squalene epoxidase, a key step in the sterol biosynthesis pathway of fungi. This inhibition leads to an accumulation of squalene, which is toxic to fungal cells, and a depletion of ergosterol, an essential component of the fungal cell membrane. The result is disrupted membrane integrity and fungal cell death.
Terbinafine is approved in Hong Kong for the treatment of tinea corporis (ringworm), tinea cruris (jock itch), tinea pedis (athlete’s foot), and onychomycosis (fungal nail infection) caused by susceptible dermatophyte species. The medication is effective for both skin and nail infections, with dosing duration adjusted to the site of infection.
This article provides educational information about terbinafine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
